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Abstract
Background: Integrin α3 (ITGA3) gene mutations are associated with Interstitial Lung disease, Nephrotic syndrome
and Epidermolysis bullosa (ILNEB syndrome). To date only six patients are reported: all carried homozygous ITGA3
mutations and presented a dramatically severe phenotype leading to death before age 2 years, from multi-organ
failure due to interstitial lung disease and congenital nephrotic syndrome. The involvement of skin and cutaneous
adnexa was variable with sparse hair and nail dysplasia combined or not to skin lesions ranging from skin fragility
to epidermolysis bullosa-like blistering.
Results: We report on two siblings of 13 and 9 years born to non-consanguineous healthy parents, who display
growth delay, severe pulmonary fibrosis with fatigue, dyspnea on exertion and wheezing, atrophic skin with
erythematosus lesions, rare eyelashes/eyebrows and pachyonychia. By exome sequencing, we identified two
unreported ITGA3 missense mutations, c.373G>A (p.(G125R)) in exon 3 and c.821G>A (p.(R274Q)) in exon 6,
affecting highly conserved residues in the integrin α3 extracellular N-terminal β-propeller domain. Homology
modelling of α3β1 heterodimer fragment, encompassing the mutation sites, showed that G125 plays a pivotal
structural role in the β-propeller, while R274 might prevent the interaction between integrin and urokinase
complex.
Conclusion: We report a variant of ILNEB syndrome in two siblings differing from the previously reported patients
in the lack of nephrotic impairment and survival beyond childhood.
Our siblings are the first reported compound heterozygous for ITGA3 mutations; this state as well as the
hypomorphic nature of their p.(R274Q) mutation likely account for their survival.
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Background
The clinical and genetic heterogeneity of genodermatoses is
well exemplified by Epidermolysis Bullosa (EB). Indeed, the
EB classification has been recently revised to incorporate
the growing list of causative genes and recommends to use
a systematic “onion skin” approach which takes into ac-
count successive layers of clinical, immunohistochemical
and molecular findings [1, 2]. One of the four main EB sub-
types, the Junctional EB (JEB), where the cleavage plain of
blister formation is within the lamina lucida, comprises
forms involving the genes for integrin subunits α6 (ITGA6,
OMIM*147556), β4 (ITGB4, OMIM*147557) and α3
(ITGA3, OMIM*605025) [3, 4]. In particular, the ITGA3
gene has been recently associated to a generalised JEB with
respiratory and renal involvement (JEB-RR) or Congenital
Interstitial Lung disease, Nephrotic syndrome and Epider-
molysis bullosa (ILNEB, OMIM#614748). So far, six unre-
lated patients with ILNEB syndrome carrying homozygous
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mutations in ITGA3 gene are reported [4–7]. All these pa-
tients developed in the first months of life severe interstitial
lung disease and renal failure leading to death in early in-
fancy, some displayed sparse hair, onychodystrophy and cu-
taneous alterations, ranging from blistering and skin
erosion to epidermolysis bullosa-like phenotype. The slight
expression or lack of apparent cutaneous defects might
have been not definitive, as these signs are hardly detectable
in the first months of life [5–7].
Integrins are transmembrane proteins with a large extra-
cellular portion and a small cytoplasmic domain. Through
tightly regulated adhesions with ligands, collectively known
as the “integrin adhesome”, integrins mediate cell-to-cell
bridges and cell-to-extracellular matrix interactions playing
a key role in cell scaffolding and signalling activity [8, 9].
They are obligate heterodimers of α and β chains and 22
different integrins result in mammals from the combination
of eighteen α with eight β subunits. In particular, integrin
α3β1 is a receptor for laminins, is widely expressed in the
epithelia, especially in lung, kidney and skin, and exerts a
fundamental role in the structural and functional
organization of these multi-compartment organs as proved
by disruption of basement-membrane structure and com-
promised tissue homeostasis of these organs in α3 full- and
organ-specific-knockout mouse models [10–14].
Here we report on two 13 and 9 year-old sibs display-
ing a clinical phenotype resembling that of ILNEB syn-
drome in the pulmonary and dermatological alterations,
but differing in the lack of renal involvement. In the two
sibs exome sequencing highlighted a compound hetero-
zygosity for two unreported missense mutations in the
ITGA3 gene, both affecting the integrin α3 extracellular
β-propeller domain, although with a different predicted
effect. The unique combination of two different ITGA3
mutations might account for the siblings’ clinical presen-
tation, which may be classified as mild “variant” of the
ILNEB syndrome.
Results
Clinical reports
We report on two affected siblings from a non-
consanguineous family presenting with a syndromic
phenotype as they shared since the first years of life
erythematous skin erosions and respiratory distress
with severe air-trapping (Fig. 1). Lung disease is more
severe in the elder sister (II-1), while skin involvement
is definitely more pronounced in the brother (II-2).
Patient II-1
The index case, II-1 (Fig. 1a), is currently 13 years old. An-
amnestic records recall an uneventful gestation till the
28th week when foetal growth retardation and oligohy-
dramnios not associated with placental dysfunction were
observed. Labour was induced at the 32th week with
caesarean section. Her body weight at birth was 2470 g
(90th centile) and length 44 cm (75th centile). On day 21st,
she was hospitalized for sepsis due to Streptococcus B in-
fection and was treated with ampicillin and gentamicin.
Two days after antibiotics therapy discontinuation, she
had a sepsis relapse and angulomandibular adenitis.
She had no major infections in the first years of life, des-
pite severe weight (<3rd centile) and height (3rd centile)
deficits. She displayed sparse eyebrows and eyelashes, fine
hair, thickened nails and atrophic and erythematous le-
sions on the legs. Vesicles at popliteal fossae appeared in a
few occasions, apparently induced by heating or sweat,
but resolved with no visible signs. Both growth delay and
dermatologic signs were recorded throughout develop-
ment (Fig. 1b) and persist up to the present age. Since age
4, she had recurrent respiratory infections and several epi-
sodes of pneumonia requiring hospital admissions and she
initiated to have breathlessness and severe limitation of
day-life activities.
At 6 years of age she had normal oxygen saturation in
ambient air at rest, but she had a dramatic effort intoler-
ance, diffuse velcro rales and wheeze. Computed tomog-
raphy (CT) evaluation showed interstitial pulmonary
disease with diffuse mosaic attenuation and minimal calcifi-
cation in the right para-tracheal localization (Fig. 1d, left).
Lung function test evidenced severe air trapping (residual
volume/total lung capacity (RV/TLC) 78.31 (290 %); forced
vital capacity (FVC) was initially about 30 %, after pro-
longed treatment her best was 57 %; forced expiratory vol-
ume in the 1st second (FEV1) 30-40 %, O2 saturation
>97 %). Fiberbronchoscopy was normal and no relevant ab-
normalities with broncho-alveolar lavage were detected.
Ventilation-perfusion scintiscan pointed out an uneven dis-
tribution between the lungs (ventilation left 32 % versus
right 68 %; perfusion left 16 % versus right 83 %). Since age
8, she reached a stable state which enabled her crossing out
from the waiting list for lung transplantation.
At age 11y, bone age study assessed a delay of 1 year;
magnetic resonance imaging showed the hypophysis was
reduced in size compared to age; low vitamin D and nor-
mal IGF1 values were recorded. Growth continued to be
stunted with body weight <3°, height at 3°-10° and BMI
<<3°. Cardiologic evaluation evidenced slight mitral insuf-
ficiency without clinical relevance. Stenosis of the lacrimal
ducts with recurrent lacrimation and abnormal teeth
eruption were observed. She suffered from gingivitis and
oral candidiasis.
Haematological and urine tests, arterial blood pressure
and renal ultrasound were repeatedly normal up to the
present age (Fig. 1e).
Patient II-2
II-2 (Fig. 1a), currently 9 years old, was born at term
(2850 g) after an uneventful pregnancy. In the first years
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of life, he showed sparse and rare eyebrows and eyelashes,
pachyonychia at toenails, erythematous lesions on cheeks,
chin, neck and limbs and marked skin atrophy with focal
areas of hypo/hyper-pigmentation on the neck and limbs.
Persistent and multiple erosions involving trauma-
exposed skin areas were found at subsequent clinical
evaluation (Fig. 1c). Growth parameters were low: at age
3.5y weight was at 25th centile and stature at 15th centile
and at 8y weight was at 25th centile, stature at 50th centile
and cranial circumference at 10-25th centile.
He had no major infections and normal effort tolerance;
chest examination was normal. Pulmonary function test
showed air trapping (RV/TLC 42.56 (160 %) and CT scan
revealed an interstitial pulmonary disease with air trapping
in both lungs (Fig. 1d, right), ventilation-perfusion
scintiscan showed minimal inhomogeneity in the lungs
(ventilation left 43 % versus right 58 %; perfusion left 44 %
versus right 56 %) and O2 saturation 98 %.
Cardiologic evaluation at the age of 7y revealed a bicuspid
aortic valve and a mild mitral insufficiency. At 9 years of
age renal ultrasound is normal (Fig. 1e) and the blood and
urine parameters reflecting renal function are all in the nor-
mal range.
Genomic analysis
The sibs were referred to our laboratory following the
negative tests for the CFTR (OMIM*602421) and SFTP-C
(OMIM*178620) genes which are implicated in perinatal
respiratory distress.
Fig. 1 Clinical manifestations in the affected sibs. a Pedigree of the patients’ family. The arrow points to the index case. b Skin and cutaneous
adnexa signs of II-1. To note sparse eyelashes, absent eyebrows, dysplastic nails, atrophic areas and diffuse erythema on the lower part of the leg.
c Dermatologic changes of II-2. Rare eyelashes and eyebrows, pachyonychia, marked skin atrophy and hypopigmentation with focal areas of
erythema at extensor limb surfaces and erosions on the legs are shown. d Tomographic scan of the chest of II-1 (7y) and II-2 (5y). Note the diffuse
distortion of the pulmonary structure and multiple peripheral areas with reduced density/diffuse ground glass opacity suggesting air-trapping. e
Renal ultrasound of II-1 (13y) and II-1 (9y) reveals the absence of structural defects in kidneys. A mild asymmetry of the left kidney can be seen
for II-1
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Due to growth retardation, poikiloderma-like skin lesions
on face, neck and limbs, nail dystrophy, hypotrichosis and
recurrent infections the USB1 (OMIM*613276) gene, re-
sponsible for Poikiloderma with Neutropenia (PN;
OMIM#604173) [15] was tested, but no mutations were de-
tected. Whole Exome Sequencing was then performed on
sibs and parents genomic DNA to disclose the causative
gene, under the assumption of autosomal recessive inherit-
ance. Following sequence alignment, about 80,000 variants
emerged in the whole pedigree and 34,390 were globally
found to be shared by the affected sibs (Fig. 2a). Special at-
tention was given to the set of genes involved in autosomal
recessive Dyskeratosis Congenita for its clinical overlap
with PN [16], but only common reported variants were ob-
served. Subsequent filtering steps, that sorted out variants
potentially affecting coding sequences (i.e. nonsynonymous,
nonsense or located in the canonical splice-site region) and
with a Common Allele Frequency (CAF) <0.01, cut down
the number of variants to 882 (Fig. 2a). As no consanguin-
ity has been reported within the family, we selected 22 vari-
ants shared by the two sibs, carried by the parents in
heterozygous condition and focused on 12 sequence
changes, predicted to be damaging by PolyPhen-2 [17] and/
or by SIFT [18] score, in 4 candidate genes (Fig. 2a). After
gene prioritization, the only candidate gene carrying bialle-
lic alterations and consistent with the clinical phenotype
was ITGA3. The two different missense changes, c.373G>A
(p.(Gly125Arg)) in exon 3, inherited from the mother, and
c.821G>A (p.(Arg274Gln)) in exon 6, inherited from the
father, were not found in any query of dbSNP-v138 [19],
1000 Genomes Project [20] and 60 in-house controls, ex-
cept for c.821G>A, which has been recently reported in
ExAC [21] browser at 1 out of 120,640 alleles
(rs745505565).
Sanger sequencing confirmed that the two sibs were
compound heterozygotes and their parents were healthy
carriers (Fig. 2b, c). Transcripts analysis evidenced that both
mutant alleles were expressed in the patients (Fig. 2d).
The two identified mutations affect amino acid resi-
dues, G125 and R274, located in α3 extracellular β-
propeller domain, which are highly conserved through
evolution (Fig. 2e). The G125 residue is invariant in
orthologous alpha chains encoded by the ITGA3 gene in
other species and in all paralogous alpha chains found in
humans (α1 to α11, αV, αIIb, αD, αE, αL, αM, αX), while
the R274 residue is invariant in orthologous, but not in
paralogous alpha chains (data not shown).
Bioinformatic mutation analyses
Additional file 1 summarises the in silico predicted effects
of the c.373G>A (p.(Gly125Arg)) and c.821G>A
(p.(Arg274Gln)) mutations [see Additional file 1]. In brief
the p.(G125R) substitution is deleterious by all the 13
accessed algorithms, while the lower values assigned by
most prediction software to p.(R274Q) suggest it might be
a hypomorphic mutation.
Furthermore, to make use of predictions concerning
the function of the mutant α3 subunits by focussing on
most α3 extracellular portion, i.e. the β-propeller, the
thigh and part of the calf-1 domain (Fig. 3a), we built a
model of the heterodimer α3β1 using a fragment of the
human α5β1 ectodomain (Protein Data Bank code 3iv4)
[22]. Although not complete, the model shown in Fig. 3b
encompasses the sites of the mutations identified in our
sibs. G125 (red spacefill in Fig. 3b) occurs in the type II
turn that precedes the second blade of the propeller.
G125 is buried, has a positive ɸ angle and cannot be
substituted by other residues whose lateral chain would
cause steric hindrance. This feature together with the high-
est conservation of this residue in both orthologous and
paralogous α chains attests it has a special structural role
in the β-propeller domain. R274 (orange spacefill in
Fig. 3b) occurs at the tip of the second strand of the fourth
blade and interacts with residues of the β1 subunit (white
in Fig. 3b). R274 is invariant in orthologous but not in
paralogous α chains, suggesting it might be necessary for
some specific function of the α3 chain, although it might
not play a pivotal structural role in the propeller as G125
does.
Discussion
We describe two siblings carrying unreported missense
mutations in the ITGA3 gene, which is responsible for
Interstitial Lung disease, congenital Nephrotic syndrome
and Epidermolysis Bullosa (ILNEB). At difference of the
six ILNEB patients so far reported, who all died within
the age of 19 months from multi-organ failure, our sibs
overcome childhood and are now 13 (II-1) and 9 (II-2)
years old, and manifest a mild clinical phenotype due to
the lack of overt kidney alterations.
Figure 4 provides an overview of the mutations identi-
fied in all ILNEB patients and their clinical features re-
ferred to skin, lung and kidneys involvement.
All patients share a severe early onset interstitial pul-
monary disease, documented in our siblings by a dis-
torted pulmonary architecture at CT chest scan
(Fig. 1d). Variants in modifier genes and the personal
history of the younger brother, starting from birth at
term and less impaired growth parameters at difference
of his sister, may account for his milder lung disease and
his comparatively higher tolerance to physical efforts.
As regards skin involvement, a wide clinical expressivity
is observed among the described patients, ranging from the
lack of macroscopic skin abnormalities [5] to features such
as pachyonychia and fine, sparse hair, eyelashes and eye-
brows [6] coupled to mild blistering disorder [4, 7] and ero-
sions [4]. Skin and cutaneous adnexa involvement is
present in both our sibs but is more pronounced and
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diffuse in the brother who evidenced hypo/hyper-pigmenta-
tion and erythema with atrophic scarring at multiple sites
(face, neck and limbs), and persistent erosion/ulcerations
over trauma-exposed areas such as elbows and knees
(Fig. 1b).
All six patients with premature demise shared congenital
nephrotic syndrome [4, 5, 7] or attenuated renal involve-
ment [6]. Interestingly, concomitant kidney anomalies, ran-
ging from hypoplasia to hypodysplasia and to crossed fused
renal ectopia have been found in some cases [4–6, 23] sug-
gesting a central role of ITGA3 in renal development. Sur-
prisingly our sibs did not manifest signs of renal
involvement and only upon the achievement of the genetic
diagnosis targeted analyses were carried out and confirmed
the normal renal function and the absence of kidney
dysplasia/hypoplasia or renal congenital malformations
(Fig. 1e). Even if we cannot exclude microscopic kidney al-
terations, the preserved renal functionality appears a signifi-
cant contributor to our sibling’ viable phenotype.
A key to justify the clinical variability displayed by the
ILNEB patients both across and within the main affected
compartments could be represented by the causative
ITGA3 mutations.
The presence of two different alterations with a poten-
tially different functional effect instead of the homozygous
mutations detected in all six published cases may contrib-
ute to the milder phenotype of our sibs (Fig. 4a). Indeed the
paternally inherited R274G is predicted by multiple algo-
rithms and by α3β1 modelling to be a hypomorphic muta-
tion, as the replaced amino acid residue does not play a key
role in the correct folding of the α3 chain, even if it might
be involved in some α3-specific function. A possible func-
tion for R274 is offered by the results of Chapman and co-
workers, who found that α3β1 binds urokinase (uPA), a
serine protease implicated in extracellular matrix degrad-
ation, and its receptor (uPAR) with high affinity [24]. They
reported that a peptide derived from α3 encompassing
R274, (273-PRHRHMGAVFLLSQEAG-289), can compete
Fig. 2 Exome sequencing identifies unreported mutations in ITGA3
gene. a Schematic representation of the exome-data-filtering approach
under the assumption of autosomal recessive inheritance of the skin
disease with lung involvement in the family. MS: missense; SS: splice
site; STOP: nonsense; InDel: insertion and/or deletion. b The pedigree
of the siblings with the index case: the carrier status of the parents,
each bearing a different mutation, and the compound heterozygous
affected siblings are indicated. [=]: wild type allele. c DNA
electropherograms showing the c.373G>A and c.821G>A transitions in
the ITGA3 gene (NM_002204). d Agarose gel showing the RT-PCR
products amplified by two different primer pairs (F1-R1, F2-R2) in the
control cDNA (C+) as well as in the index case (II-1). The sequencing
chromatograms of the two fragments spanning the mutation sites are
provided below. C-: negative control. e Evolutionary comparison across
α3 subunit orthologs in nine animal species from human to lamprey
shows conservation of the two amino acid residues glycine 125 and
arginine 274 (NP_002195) in the siblings family
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specifically and prevent the interaction between the integrin
and the uPA/uPAR complex. The specificity of the binding
is attested by the fact that homologous peptides either de-
rived from α5 or from αv cannot compete at same way.
The uPAR/α3β1 interaction may trigger a pathway of cellu-
lar adhesion to vitronectin, especially in cells with little or
no αvβ3 [24, 25].
By surveying the functional data obtained on the in-
vestigated ILNEB patients, we note that there is a correl-
ation between the age of the demise and the presence of
the mature α3β1 heterodimer over the cell membrane.
Out of the six characterised patients, five died before
8 months and did not express the α3 subunit. Con-
versely patient 3 [4], carrying the most distal homozy-
gous mutation, a missense change affecting the calf-1
domain, which has been shown to lead to a residual ex-
pression of integrin α3β1 on cell membrane [26], passed
away at 19 months.
Although in the case of two different mutations it may
be hard to discriminate the different effects of each muta-
tion at the cellular level, we could not perform expression
studies due to the unavailability of lung and skin biopsies
from our siblings. However, we speculate that at least one
mutated protein, likely the one carrying the p.(Arg274Gln)
alteration, may be expressed and localized on the cell
membrane where it can at least partially work. A tissue-
specific penetrance of the “leaky” mutation could explain
the lack of renal involvement along with severe lung dis-
ease and overt skin anomalies.
In accordance with this hypothesis, a residual protein
activity in our sibs might justify their relatively mild
overall phenotype and survival till adolescence.
Conclusion
Our findings on ITGA3 compound heterozygous patients
with an ILNEB-like clinical presentation may account for
Fig. 3 The model of human α3β1 heterodimer. a Diagram of the mature integrin α3 subunit. Blue nuances mark the domains of the extracellular
portion, the transmembrane domain is orange and the short intracellular domain is pink. The p.(Gly125Arg) and p.(Arg274Gln) fall within the second
and the fourth FG-GAP repeats (in black) of the extracellular β-propeller domain. b Portion encompassing residues from 34 to 612 of the α3 subunit
subjected to 3D modelling is indicated by the diagonal lines. The β-propeller colour ramps from blue (N-terminus) to yellow (C-terminus) and the thigh
domain colour ramps from yellow (N-terminus) to red (C-terminus). The plexin/semaphorin/integrin (PSI), hybrid and βA domains of β1 subunit
(residues 26-465) are in white. Arrows symbolize beta-strands, curls symbolize helices. Residues G125 (red) and R274 (orange) are rendered in
spacefill mode
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underestimate of integrin α3 mutated cases and should be
kept into account in the processing of exome data from
phenotypically candidate patients born to families without
consanguinity. Furthermore, the two described siblings
may foster better comprehension of the genotype-
phenotype correlations in patients with ILNEB and over-
lapping clinical presentations.
Methods
The siblings’ parents provided written informed consent
to the genetic/genomic test. The study protocol was ap-
proved by the Research Ethics Board of ICP, Milan, Italy.
The genomic DNA of the four family members, ex-
tracted from peripheral-blood lymphocytes according to
standard protocols, was processed for exome sequencing.
Briefly, 2 μg of gDNA was fragmented by Covaris E220,
followed by end repair, A-tailing, adapter/barcode ligation
and PCR. DNA libraries for each subject have been labelled
with a different barcode, pooled and captured together on
TruSeq Exome Enrichment preparation kit (Illumina, San
Diego, CA) for exome library preparation following manu-
facturer instruction. Each pool (final concentration of 8
pmol) was sequenced on HiSeq 2500 (Illumina), running
SBS 2×101 pair end SBS protocol.
For bioinformatics analysis, read tags were aligned on
human reference genome (hg19) using bwa 0.6.1 [27].
After removing duplicate and off-target reads, GATK [28]
was used to perform a joint call of SNP and Indels using
also a set of 60 exomes of unrelated healthy individuals.
Variants were filtered after Variant Quality Score Recali-
bration and annotated to dbSNP using SnpSift. Functional
impact of each variant was predicted using snpEff [29].
Validation of possibly damaging variants detected by ex-
ome sequencing in ITGA3 was performed by Sanger se-
quencing from PCR amplicons targeted to encompass
ITGA3 variants. PCR was carried out under standard
conditions using the following primers (Fex3: 5’-
AAGAGGGTGCCCTAGAGGAG-3’, Rex3: 5’-TTGGGA
GAGCACAGGATAC-3’; Fex6: 5’-GCTGGCCATCTG-
GAGTCTAC-3’; Rex6: 5’-CTGCAAACCTCTGCAAAC
AAC-3’), then the amplicons were sequenced bidirection-
ally on an ABI3130 DNA Analyzer with BigDye chemistry
v1.1 (Applied Biosystems, Foster City, CA). Electrophero-
grams were analysed with ChromasPro software 1.42
(Technelysium Pty Ltd, Tewantin QLD, Australia) using
Fig. 4 Map of ITGA3 mutations and related clinical features. a Schematic of ITGA3 gene and localization of the identified mutations. Above the
diagram the six reported mutations, all in homozygous state (each framed by a different colour rectangle); below the two different mutations
(within rectangles with purples lines) identified in the herein described sibs. b The body compartments (skin, lung and kidney) affected in the
patients with ITGA3 mutations. Bars, in the same colour used to highlight the mutations, extend across the three main deranged systems in each
patient. The dotted dark green bar of patient 1 [6] indicates the lack of clinical skin disease with the presence of hair and nail signs. Worth noting,
no renal involvement is observed in the sibs herein studied, who are the only ITGA3-mutated patients surviving beyond the first/second year
of life
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the wild type sequence of ITGA3 gene (NG_029107.1)
as reference. Description of sequence variants has been
performed according to HGVS recommendations [30]
and ITGA3 mutations are deposited in the LOVD data-
base [31].
RT-PCR was employed for determining the effect of
the detected mutations on transcripts. RNA was iso-
lated using TRI reagent (Sigma, Saint Louis, MI) from
EBV-transformed lymphoblastoid cell lines, established
from peripheral blood lymphocytes of the elder sib II-1
(SR51711F) and healthy controls and cultured in
complete RPMI 1640 medium (EuroClone, Milano,
Italy) supplemented with 10 % foetal bovine serum
(Lonza, Walkersville, MD) and 1 % Penicillin, Strepto-
mycin and Ampicillin in a 37 °C humidified incubator
with 5 % CO2. After DNase I treatment (RNase-free,
New England Bio-Labs, Ipswich, MA), 250 ng of total
RNA were used to cDNA synthesis using the High
Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) with random hexamers. ITGA3 cDNA,
from exon 1-2 to exon 5-6 (F1: 5’-CGCTACCTGCTC
CTGGCTG-3’; R1: 5’-CCTGCATCGTGTACCCAATA-
3’) and from exon 3-4 to exon 7-8 (F2: 5’-AGT
TCTGGTCTGTGCCCACC-3’; R2: 5’-GCTCCCACAG-
CAATATCCTGAA-3’) was amplified and sequenced as
above described. Nucleotide sequences were compared
to the major ITGA3 transcript reference sequence
(NM_002204.2).
To assess the potential impact of ITGA3 identified sub-
stitutions on gene functions, we used different bioinfor-
matic prediction tools: PolyPhen-2 [17], SIFT [18], PMut
[32], SNP&GO [33], MutPred [34], SNAP2 [35], PhD-SNP
[36], META_SNP [37], Hansa [38], MutationTaster [39],
IMutant2 [40], PhastCons [41] and PhyloP [42].
Homology modelling of the heterodimer α3β1 was car-
ried out with MODELLER [43]. The template was the
crystal structure of the human α5β1 ectodomain (Protein
Data Bank code 3iv4) [22]. We aligned residues 34-612 of
integrin α3 to residues 42-642 of integrin α5 with FUGUE
[44] and borrowed the structure of integrin β1 residues 26-
465 from 3iv4 [22]. FUGUE utilizes environment-specific
substitution tables and structure-dependent gap penalties,
so that scores for amino acid matching and insertions/dele-
tions are evaluated depending on the local environment of
each amino acid residue in a known structure. Dihedral an-
gles and secondary structure were assigned with SEGNO
[45]. Figures are drawn with CHIMERA [46].
Additional file
Additional file 1: Predictions of the effects of ITGA3 mutation. In this
supplementary table we summarize the predictions of the effects of the
two ITGA3 mutations, c.373G >A and c.821G >A, obtained applying
different bioinformatic tools. (PDF 117 kb)
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